periodic fever syndrome

(redirected from Autoinflammatory syndrome)
Also found in: Wikipedia.

periodic fever syndrome

Immunology A heterogeneous group of inherited diseases of uncertain pathogenesis, in which the diagnosis is based on clinical features rather than on specific tests. See Familial Mediterranean fever, Hyper-IgD syndrome.
References in periodicals archive ?
The presence of systemic symptoms could mean the urticarial rash is not ordinary urticaria," he said, suggesting that vasculitis, Schitzler's syndrome, adult-onset Still's disease, an autoinflammatory syndrome, or urticarial dermatitis could be at play.
Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome.
Now, researchers from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health, and other institutions have discovered a new autoinflammatory syndrome, a rare genetic condition that affects children around the time of birth.
tumor necrosis factor receptor-associated periodic syndrome (13), hyper-IgD syndrome (14,15), and familial cold autoinflammatory syndrome (16).
Cryopyrin-Associated Periodic Syndromes (CAPS), Muckle-Wells Syndrome, Familial Cold Autoinflammatory Syndrome (FCAS)
This autosomal recessive inherited autoinflammatory syndrome is characterized by recurrent fever attacks, abdominal pain, lymphadenopathy, skin lesions and joint involvement.
This syndrome has fallen under the umbrella of so-called autoinflammatory diseases, which also include neonatal-onset multisystem inflammatory disease and familial cold autoinflammatory syndrome, formerly called chronic cold urticaria, Dr.
Cryopyrin-Associated Periodic Syndromes (CAPS) is a spectrum of rare inherited inflammatory conditions, including Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS).
Currently, there are no medicines approved for patients suffering from CAPS, a spectrum of rare inherited inflammatory conditions, including Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS).
The trial was designed to provide two separate demonstrations of efficacy for the IL-1 Trap, a long-acting IL-1 inhibitor, in adult patients suffering from Familial Cold Autoinflammatory Syndrome (FCAS) or Muckle-Wells Syndrome (MWS).
CIAS1-related Autoinflammatory Periodic Syndromes (CAPS) is a spectrum of rare inherited inflammatory conditions, including Familial Cold Autoinflammatory Syndrome (FCAS), Muckle-Wells Syndrome (MWS), and Neonatal Onset Multisystem Inflammatory Disease (NOMID).
The CAPS syndromes included in our program include patients with Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle Wells Syndrome (MWS).